Deborah G. Mayo & Aris Spanos 
Error and Inference [PDF ebook] 
Recent Exchanges on Experimental Reasoning, Reliability, and the Objectivity and Rationality of Science

Capitalism is historically pervasive. Despite attempts through the centuries to suppress or control the private ownership of commercial assets, production and trade for profit has survived and, ultim …

Discover how European firms operate in the global marketplace Contemporary Euromarketing examines the strategies of small and medium-sized firms that sell their products and services in international …

A practical, modern book for managers and leaders who need to know how to get the best from their teams in a 21st century business world. The world of work and the needs of people in the workplace ha …

This book provides a contemporary perspective on a broad range of international migration problems. It considers recent immigration trends and policies as well as the theory and evidence related to t …

Providing another key contribution to the immensely popular field of law and economics, this book, written by the doyen of the history of economic thought in the US, explores the dynamic relationship …

First Published in 1966.This volume adds to maritime history with information on trade in the Eastern Seas from 1793 to 1813. It is a description of conditions not a narrative of events. …

Birds of a feather flock together. We”re all in the same boat. Great minds think alike. While just figures of speech to some, they reflect a simple truth–it”s the company we keep that often determ …

It is well-known that the Swedish experiment in practical economic control was inspired by a simultaneous development of economic thought in Sweden. Despite Swedish economics being known globally, un …

The events of 11 September 2001 changed the world, and in particular the aviation community, forever. Since then, the terrorist threat continues to dominate international air travel and pose a real a …

Appraising cancer as a major medical market in the 2010s, Wall Street investors placed their bets on single-technology treatment facilities costing $100-$300 million each. Critics inside medicine cal …